nisoxetine has been researched along with Bulimia in 1 studies
nisoxetine: potent inhibitor for norepinephrine uptake into rat brain synaptosomes & brain; NM refers to (+-)-isomer; RN given refers to parent cpd; structure
nisoxetine : A secondary amino compound that is N-methyl-3-phenylpropan-1-amine substituted at position 3 by a 2-methoxyphenoxy group.
Bulimia: Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bello, NT | 1 |
| Yeh, CY | 1 |
| Verpeut, JL | 1 |
| Walters, AL | 1 |
1 other study available for nisoxetine and Bulimia
| Article | Year |
|---|---|
Binge-like eating attenuates nisoxetine feeding suppression, stress activation, and brain norepinephrine activity.
Topics: Animals; Body Weight; Brain; Bulimia; Energy Intake; Feeding Behavior; Fluoxetine; Male; Norepinephr | 2014 |